What Happened?
Redmond, AB-based Cadence-Neuroscience Appointed Kent Leyde as Chief Executive Officer
About the Company
Cadence Neuroscience is developing a next generation implantable device therapy for epilepsy. The therapy, pioneered by researchers at Mayo Clinic over the past decade, uses advanced methods to provide individualized treatment for each patient. Our core technology includes a specialized neuromodulation platform that enables these methods. Cadence is currently engaged in the engineering and testing of the platform, and preparing for additional clinical evaluations.
About the Person
Kent Leyde is Chief Executive Officer at Cadence Neuroscience. Previously, Kent held various senior HR leadership roles in the industry.
Info Source
News
Short Profile